RTOG-0815: A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patient with Intermediate-Risk Prostate Cancer
|Effective start/end date||3/1/14 → 7/31/19|
- NRG ONCOLOGY FOUNDATION, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.